Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone to improve interferon sensitivity in HCV genotype 1 non-responders
2009-016678-34Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pioglitazone in chronic hepatitis C virus infection, sponsored by Imperial College London. Primary endpoints: Change in total body insulin resistance after 12 weeks of pioglitazone, Change in hepatic insulin resistance after 12 weeks of pioglitazone and 1 more. Started Mar 2010; status: completed.
02
Drugs
pioglitazone
03
Conditions
chronic hepatitis C virus infection
Beyond the preview
Go deeper on 2009-016678-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016678-34.